Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 5 of 5 results for cg92

  1. Utilising the skills of the clinical pharmacist within the MDT for improved medicines optimisation

    the risk for patients in hospital (CG92)

    Shared learning
    Published
    1 May 2018

  2. Various modes used to reinforce NICE guidance for venous thrombo-embolism prophylaxis

    the risk for patients in hospital (CG92)

    Shared learning
    Last updated
    24 April 2015

  3. Venous thromboembolism: reducing the risk for patients in hospital (CG92)

    This guidance has been updated and replaced by NICE guideline NG89.

    Clinical guideline
    Last updated
    1 June 2015

  4. Venous thromboembolism (surgical) (CG46)

    This guidance has been updated and replaced by NICE guideline CG92.

    Clinical guideline
    Published
    23 April 2007

  5. Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)

    Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

    Evidence summary
    Published
    24 May 2016